TPO and Splenomegaly: When comparing anti-TPO positive (anti-TPO (+)) and anti-TPO negative (anti-TPO (−)) patients, there were no significant differences in age, sex, ethnicity, or co-morbidities such as HCV, HBV, liver disease, neoplasia, or splenomegaly (Table 3).